Deep learning based linear energy transfer calculation for proton therapy.

Journal: Physics in medicine and biology
PMID:

Abstract

This study aims to address the limitations of traditional methods for calculating linear energy transfer (LET), a critical component in assessing relative biological effectiveness (RBE). Currently, Monte Carlo (MC) simulation, the gold-standard for accuracy, is resource-intensive and slow for dose optimization, while the speedier analytical approximation has compromised accuracy. Our objective was to prototype a deep-learning-based model for calculating dose-averaged LET (LET) using patient anatomy and dose-to-water (D) data, facilitating real-time biological dose evaluation and LET optimization within proton treatment planning systems.. 275 4-field prostate proton Stereotactic Body Radiotherapy plans were analyzed, rendering a total of 1100 fields. Those were randomly split into 880, 110, and 110 fields for training, validation, and testing. A 3D Cascaded UNet model, along with data processing and inference pipelines, was developed to generate patient-specific LETdistributions from CT images and D. The accuracy of the LETof the test dataset was evaluated against MC-generated ground truth through voxel-based mean absolute error (MAE) and gamma analysis.The proposed model accurately inferred LETdistributions for each proton field in the test dataset. A single-field LETcalculation took around 100 ms with trained models running on a NVidia A100 GPU. The selected model yielded an average MAE of 0.94 ± 0.14 MeV cmand a gamma passing rate of 97.4% ± 1.3% when applied to the test dataset, with the largest discrepancy at the edge of fields where the dose gradient was the largest and counting statistics was the lowest.This study demonstrates that deep-learning-based models can efficiently calculate LETwith high accuracy as a fast-forward approach. The model shows great potential to be utilized for optimizing the RBE of proton treatment plans. Future efforts will focus on enhancing the model's performance and evaluating its adaptability to different clinical scenarios.

Authors

  • Xueyan Tang
    Department of Radiation Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States of America.
  • Hok Wan Chan Tseung
    Department of Radiation Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States of America.
  • Douglas Moseley
    Department of Radiation Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States of America.
  • Alexei Zverovitch
    Google Health, London, United Kingdom.
  • Cian O Hughes
    DeepMind, London, EC4A 3TW, UK.
  • Jon George
    Google Inc, Mountain View, CA, United States of America.
  • Jedediah E Johnson
    Department of Radiation Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States of America.
  • William G Breen
    Department of Radiation Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States of America.
  • Jing Qian
    Department of Nephrology, Huashan Hospital, Fudan University, Shanghai 200040, China.